View study details on clinicaltrials.gov.
Clinical Trial FAQs
Information for patients and study volunteers, including frequently asked questions.
A Phase III Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group Study To Evaluate The Efficacy And Safety Of Fenebrutinib Compared With Ocrelizumab In Adult Patients With Primary Progressive Multiple Sclerosis
Location: REDI (East Bay); Sutter East Bay Medical Foundation
Please contact: David Harris, RN about GN41791
Joanna A. Cooper, M.D., David Eric Collins, MD
Bradley T Wrubel, MD, Aryn Earnhardt, NP, Matthew W. Arnold, M.D., Antonio J Silva-Sayago, MD, Lynn Jehle, NP
Investigator: Lawrence Dickinson, M.D
Using Electronic Health Records to Identify Gaps in Migraine Headache Care: A Step Towards Improving Patient Outcomes
Mindfulness and Migraine: A Randomized Controlled Trial
Investigator: Sylvia Sudat, PhD